Scarica l'app Stockscreener
1.40
2.19%
0.03
Pre-mercato:
1.40
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché HRTX Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$1.37
Aprire:
$1.36
Volume 24 ore:
2.50M
Relative Volume:
1.35
Capitalizzazione di mercato:
$256.71M
Reddito:
$137.74M
Utile/perdita netta:
$-27.97M
Rapporto P/E:
-8.75
EPS:
-0.16
Flusso di cassa netto:
$-9.61M
1 W Prestazione:
+3.70%
1M Prestazione:
+27.27%
6M Prestazione:
-27.46%
1 anno Prestazione:
-12.50%
Intervallo 1D:
$1.32
$1.44
Intervallo di 1 settimana:
$1.30
$1.44
Portata 52W:
$0.9999
$2.68
Heron Therapeutics Inc Stock (HRTX) Company Profile
Nome
Heron Therapeutics Inc
Settore
Industria
Telefono
(858) 251-4400
Indirizzo
4242 CAMPUS POINT COURT, SUITE 200, SAN DIEGO, CA
Confronta HRTX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
HRTX
Heron Therapeutics Inc
|
1.40 | 251.21M | 137.74M | -27.97M | -9.61M | -0.16 |
|
VRTX
Vertex Pharmaceuticals Inc
|
455.71 | 114.69B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
752.62 | 77.91B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
850.95 | 54.05B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
391.50 | 52.52B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
196.92 | 42.02B | 447.02M | -1.18B | -906.14M | -6.1812 |
Heron Therapeutics Inc Stock (HRTX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-06-09 | Iniziato | H.C. Wainwright | Buy |
| 2024-06-13 | Iniziato | Rodman & Renshaw | Buy |
| 2024-04-23 | Iniziato | CapitalOne | Overweight |
| 2024-03-13 | Reiterato | Needham | Buy |
| 2020-05-27 | Iniziato | Guggenheim | Buy |
| 2020-02-20 | Reiterato | Needham | Buy |
| 2019-01-16 | Reiterato | Needham | Buy |
| 2018-04-05 | Iniziato | Evercore ISI | Outperform |
| 2018-03-19 | Reiterato | Mizuho | Buy |
| 2018-03-01 | Reiterato | Needham | Buy |
| 2018-01-03 | Iniziato | Leerink Partners | Outperform |
| 2017-09-27 | Iniziato | Northland Capital | Outperform |
| 2017-02-27 | Iniziato | Needham | Buy |
| 2016-10-26 | Iniziato | Aegis Capital | Buy |
| 2016-09-06 | Ripresa | Lake Street | Buy |
| 2016-05-03 | Iniziato | Cantor Fitzgerald | Buy |
| 2015-12-10 | Iniziato | Lake Street | Buy |
| 2015-09-23 | Reiterato | Leerink Partners | Outperform |
| 2015-09-02 | Iniziato | BofA/Merrill | Buy |
| 2015-08-03 | Reiterato | Brean Capital | Buy |
| 2015-06-30 | Reiterato | JMP Securities | Mkt Outperform |
| 2015-06-19 | Reiterato | Leerink Partners | Outperform |
| 2014-08-07 | Iniziato | Noble Financial | Buy |
Mostra tutto
Heron Therapeutics Inc Borsa (HRTX) Ultime notizie
Heron Therapeutics, Inc. (NASDAQ:HRTX) Stock Catapults 27% Though Its Price And Business Still Lag The Industry - simplywall.st
Heron Therapeutics, Inc. (NASDAQ:HRTX) is favoured by institutional owners who hold 57% of the company - Yahoo Finance
Heron Therapeutics Inc (HRTX) can make a big difference with a little luck - setenews.com
Heron Therapeutics Stock Jump Looks Great, But How Secure Is That Gain? - Trefis
Activity Recap: Will Heron Therapeutics Inc stock deliver long term returnsDividend Hike & Weekly Market Pulse Updates - BỘ NỘI VỤ
San Diego Biotech Firm Heron Therapeutics Shifts Operations to North Carolina - MSN
What analysts say about Heron Therapeutics Inc stockGrowth Stock Opportunities & 5 Stocks Every Investor Should Own - earlytimes.in
Market Sentiment Around Loss-Making Heron Therapeutics, Inc. (NASDAQ:HRTX) - simplywall.st
Can Heron Therapeutics Inc. stock sustain institutional interestMarket Trend Report & High Return Trade Guides - Newser
Can Heron Therapeutics Inc. (AXD2) stock expand revenue streamsWeekly Profit Analysis & Fast Entry and Exit Trade Plans - Newser
How cyclical is Heron Therapeutics Inc. (AXD2) stock compared to rivalsJuly 2025 Setups & Fast Entry High Yield Tips - Newser
Heron Therapeutics announces inclusion of Aponvie (aprepitant) - marketscreener.com
Heron Therapeutics Announces Inclusion of APONVIE® - GlobeNewswire
Why Heron Therapeutics Inc. stock attracts high net worth investorsWeekly Profit Report & Detailed Earnings Play Strategies - Newser
Heron Therapeutics (Nasdaq: HRTX) APONVIE cited in fifth consensus PONV care guidelines - Stock Titan
Heron Therapeutics Injects New Life Into Growth Story With ZYNRELEF And APONVIE Momentum - RTTNews
Will Heron Therapeutics Inc. stock deliver long term returnsCPI Data & Risk Controlled Swing Trade Alerts - Newser
History Review: Can Heron Therapeutics Inc. stock sustain market leadershipJuly 2025 WrapUp & Daily Profit Focused Screening - BỘ NỘI VỤ
Heron Therapeutics, Inc. (NASDAQ:HRTX) Receives $4.50 Average Price Target from Brokerages - Defense World
Heron Therapeutics (HRTX) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
What the Latest News Means for Eurotex Industries and Exports Limited Stock InvestorsProtective Put Strategies & Small Capital Trading Growth - earlytimes.in
What analysts say about Heron Therapeutics Inc AXD2 stockMarket Sentiment Surveys & Build a Dividend-Powered Portfolio - earlytimes.in
Is Heron Therapeutics Inc. stock gaining market sharePortfolio Gains Summary & Low Risk High Win Rate Stock Picks - BỘ NỘI VỤ
Heron Therapeutics, Inc. (NASDAQ:HRTX) Given Consensus Recommendation of "Hold" by Analysts - MarketBeat
Trading Action: Can Heron Therapeutics Inc. stock surprise with earnings upsideQuarterly Trade Report & High Accuracy Swing Entry Alerts - BỘ NỘI VỤ
Heron Therapeutics, Inc. $HRTX Shares Sold by Orchard Capital Management LLC - MarketBeat
Jefferies Financial Group Inc. Acquires 344,200 Shares of Heron Therapeutics, Inc. $HRTX - MarketBeat
Is Heron Therapeutics Inc AXD2 a good long term investmentFundamental Strength Indicators & High Yield Stock Picks - earlytimes.in
Heron Therapeutics, Inc. (HRTX) Analyst insights, Price targets and Recommendations - Yahoo Finance UK
Can Heron Therapeutics Inc. (AXD2) stock attract ESG investmentsJuly 2025 Price Swings & AI Based Buy and Sell Signals - newser.com
Why Heron Therapeutics Inc. (AXD2) stock remains stableWeekly Market Report & Daily Profit Maximizing Trade Tips - newser.com
How Heron Therapeutics Inc. (AXD2) stock responds to bond marketInsider Buying & AI Enhanced Trading Signals - newser.com
How Heron Therapeutics Inc. (AXD2) stock moves in volatile trading sessionsJuly 2025 Retail & Short-Term Trading Alerts - newser.com
Heron Therapeutics Inc. stock daily chart insightsRecession Risk & Weekly High Potential Stock Alerts - newser.com
Is Heron Therapeutics Inc. (AXD2) stock prepared for digital transitionQuarterly Market Summary & Stepwise Entry and Exit Trade Signals - newser.com
Heron Therapeutics Inc. stock prediction for this weekTrade Entry Report & Expert Approved Trade Ideas - newser.com
Ready to Jump After Recent Trade: Heron Therapeutics Inc (HRTX) - setenews.com
Ranking Heron Therapeutics Inc. among high performing stocks via toolsExit Point & Low Drawdown Trading Strategies - newser.com
Will Heron Therapeutics Inc. stock benefit from automationTreasury Yields & Fast Moving Stock Trade Plans - newser.com
Why Heron Therapeutics Inc. (AXD2) stock could rally stronglyMarket Sentiment Summary & Daily Chart Pattern Signal Reports - newser.com
Heron Therapeutics Inc Azioni (HRTX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Heron Therapeutics Inc Azioni (HRTX) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Morgan Adam | Director |
Aug 08 '25 |
Buy |
1.50 |
1,766,546 |
2,649,819 |
8,753,290 |
0.36%
1.05%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):